ALG2 and Congenital Myasthenic Syndrome With Glycosylation Defect: Association Evidence

At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Provenance

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

ALG2

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Congenital Myasthenic Syndrome With Glycosylation Defect

5 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Phenotype

36 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Mechanism overlap

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Literature

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Provenance

5 references

Every source and publication cited across this dossier, as one numbered reference list.